Ascendis Pharma's total assets for Q1 2026 were €2.01B, an increase of 54.02% from the previous quarter. ASND total liabilities were €1.52B for the fiscal quarter, a 3.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.